prosensa holding nv (RNA:NASDAQ GS)
Kenneth H. Fischbeck M.D.
Member of Scientific & Clinical Advisory Board, Prosensa Holding N.V.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dr. Kenneth H. Fischbeck,,M.D. has been chief of the Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, USA since 1998. Dr. Fischbeck serves as Member of Scientific & Clinical advisory board of Prosensa Therapeutics B.V. In 2000 he was elected to the Institute of Medicine of the National Academy of Sciences. He serves on advisory boards for the Hereditary Disease Foundation, the Spinal Muscular Atrophy ...
J.H. Oortweg 21Phone: 31 71 332 2100
Leiden, Zuid-Holland 2333 CH
Fax: 31 71 332 2088
Board Members Memberships*There is no Board Members Memberships data available.
Johns Hopkins University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark J. Ahn Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark J. Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|